MedTrace Logo

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX )

NCT05281692 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 205

Last updated 2022-10-18

No results posted yet for this study

Summary

This is a research study to evaluate the clinical utility of the Enhanced Preservation Media with Integrated Extraction (EPM-IX)

Conditions

Interventions

DIAGNOSTIC_TEST

Enhanced Preservation Media (EPM-IX)

EPM-IX is a clinical specimen collection medium that inactivates pathogens, preserves nucleic acids, and integrates DNA/RNA purification. EPM-IX eliminates the need for additional extraction reagents or kits and purifies DNA/ RNA from the entire sample to enable optimal test performance.

Sponsors & Collaborators

  • Convergent Genomics, Inc.

    lead NETWORK

Principal Investigators

  • Paul Yonover, MD · UroPartners, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-02
Primary Completion
2022-03-21
Completion
2022-03-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05281692 on ClinicalTrials.gov